Premier Inc (NASDAQ:PINC) stock price target upped to $36.00, reported today by Zacks Investment Research
- Updated: September 17, 2016
Showing a price of $33.74, Premier Inc (NASDAQ:PINC) traded 0.03% lower on the day. The last stock price close is up 3.15% relative to the 200-day average, compared with the Standard & Poor’s 500 Index which has fallen -0.01% over the same time period. The company has logged a 50-day moving average of $32.14 and two hundred day average of $32.75. Trade volume was was up over the average, with 787,245 shares of PINC changing hands over the typical 509,191 shares.
In a report released on Thursday August 18 2016 Zacks Investment Research bumped up the target price of Premier Inc (NASDAQ:PINC) from $0 to $36 indicating a possible upsideof 0.07%.
On 8/05/2016, Credit Suisse reported on Premier Inc(NASDAQ:PINC) upped the target price from $0.00 to $39.00. At the time, this indicated a possible upside of 0.21%.
Recent Performance Chart:
A total of 14 equity analysts have reported on the company. Nine analysts rate the company a strong buy, six firms rate the company a buy, one firm rate the stock a hold, 0 rate the company to underperform, and finally 0 analystsrate the company as sell with a one year target price of $39.61
Premier Inc has a PE of 24 with a 52 week low of $29.68 and a 52 week high of $37.31 and has a market cap of $0.0.
About Premier Inc (NASDAQ:PINC)
Premier, Inc. is a healthcare improvement company. The Company is uniting an alliance of approximately 3, 600 United States hospitals and approximately 120, 000 other providers to transform healthcare. The Company operates healthcare group purchasing organizations and also provides integrated data and analytics, supply chain solutions, advisory services, performance improvement collaborative and other services. The Company plays a role in the healthcare industry, and collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.